False-positives and Clinical Heterogeneity among Youth at Clinical High-risk for Psychosis: Clinical and Ethical Implications for Assessment and Treatment

Simple item page
dc.contributor.authorMillman, Zachary B.
dc.date.accessioned2019-09-24T13:22:13Z
dc.date.available2019-09-24T13:22:13Z
dc.date.issued2018-06-15
dc.description.abstractEarly detection and prevention of psychosis among those showing early, attenuated manifestations has become an international initiative. Multiple ethical and clinical challenges, however, complicate these efforts. We discuss contextual considerations in the identification of psychosis-risk, the complicating role of comorbidities in clinical decision-making, and limitations to the extant psychosocial intervention literature. Factors such as clients’ life experiences, cultural background, and co-occurring psychopathology may all influence whether putative attenuated psychotic signs are considered risk factors for psychosis. Once a high-risk label is ascribed, these and other considerations influence the degree to which available interventions are appropriate for presenting concerns. We suggest that brief screening instruments may promote more accurate identification of psychosis-risk; we also contend that a modular, needs-based treatment model may begin to address the ethical and clinical concerns associated with providing early intervention to people identified as at-risk, even if psychosis is not the ultimate clinical outcome.en_US
dc.description.sponsorshipThis work was supported in part by funding from National Institute of Mental Health Grants R01MH112612 and R34MH110506, and the Maryland Department of Health and Mental Hygiene, Behavioral Health Administration through the Center for Excellence on Early Intervention for Serious Mental Illness (OPASS# 14-13717G/M00B4400241), to Jason Schiffman.en_US
dc.description.urihttps://jemh.ca/issues/v9/documents/JEMH%20article%20prediction%208%20-%20copy-edited%20by%20AJY.pdfen_US
dc.format.extent20 pagesen_US
dc.genrejournal articlesen_US
dc.identifierdoi:10.13016/m22dmt-4mwv
dc.identifier.citationZachary B. Millman, False-positives and Clinical Heterogeneity among Youth at Clinical High-risk for Psychosis: Clinical and Ethical Implications for Assessment and Treatment, Journal of Ethics in Mental Health, vol. 9, 2014-2016.en_US
dc.identifier.urihttp://hdl.handle.net/11603/14592
dc.language.isoen_USen_US
dc.publisherJournal of Ethics in Mental Healthen_US
dc.relation.isAvailableAtThe University of Maryland, Baltimore County (UMBC)
dc.relation.ispartofUMBC Psychology Department Collection
dc.rightsThis item is likely protected under Title 17 of the U.S. Copyright Law. Unless on a Creative Commons license, for uses protected by Copyright Law, contact the copyright holder or the author.
dc.subjectclinical high-risken_US
dc.subjectattenuated psychosis syndromeen_US
dc.subjectethicsen_US
dc.subjectassessmenten_US
dc.subjecttreatmenten_US
dc.titleFalse-positives and Clinical Heterogeneity among Youth at Clinical High-risk for Psychosis: Clinical and Ethical Implications for Assessment and Treatmenten_US
dc.typeTexten_US

Files

License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.56 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

UMBC Psychology Department